Huang FS, Zwerdling T, Stern LE, Ballard ET, Warner BW. Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.
J Pediatr Hematol Oncol 2001;
23:609-11. [PMID:
11902306 DOI:
10.1097/00043426-200112000-00011]
[Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Numerous children have been treated successfully for cancer and are surviving into adulthood. As this population has aged, an increasing number of secondary malignancies has emerged. Renal cell carcinoma (RCC) is a rare tumor in childhood and has not been documented previously to occur after treatment of acute promyelocytic leukemia (APL). This report describes the clinical course of APL treated in a child in whom RCC subsequently developed during adolescence approximately 5 years after therapy.
Collapse